Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Carocare Wellness vs Ivim Health

Carocare Wellness
Graded #378

Lower grade

vs+1.5
Ivim Health
Graded #338

Higher grade

The verdict

Ivim Health takes it — 59.6/100 to 58.1/100, but only just.

Ivim Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Ivim Health is a telehealth weight-loss programme selling compounded semaglutide starting at $149/mo and compounded tirzepatide starting at $224/mo, each quoted with medication and programme charges included. Carocare Wellness is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueCarocare Wellness +15
59
44
Dose & formulationEven
64
64
Clinical oversightIvim Health +10
69
79
Labs & monitoringCarocare Wellness +1
53
52
FulfillmentIvim Health +5
60
65
Contract termsIvim Health +35
20
55
Carocare Wellness · left barIvim Health · right bar

The numbers

MetricCarocare WellnessIvim Health
WeighScore58.1/10059.6/100
GradeCC
Scorecard rank#378#338
Semaglutide$170/mo (compounded)$149/mo (starting dose, medication and programme fee, compounded)
Tirzepatide$200/mo (compounded)$224/mo (starting dose, medication and programme fee, compounded)
Coverage1 stateCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Carocare Wellness

Graded #378 · C

Strengths

  • Real, named local clinic in Houston with hands-on provider support, in-person visits and Google-reviewed patient experiences
  • Low entry pricing — semaglutide from $170 and tirzepatide from $200 in month 1, with 3-month bundles ($500 / $600) that cut the effective monthly cost
  • Packages include ongoing provider support, supplies and delivery
  • Also offers IV hydration and NAD+ if you want broader wellness services in one place

Where it loses points

  • Houston/Texas only — no nationwide telehealth, so it is not an option outside the local area
  • Dose-escalating pricing climbs steeply (semaglutide reaches $330 by month 5; tirzepatide $425 by month 6)
  • Compounding pharmacy is not named, and there is no LegitScript or published clinical-oversight detail
  • Small single-location operation with no patient portal — booking and support run through Calendly and direct contact
  • Compounded semaglutide and tirzepatide only — no brand-name or oral options
Ivim Health

Graded #338 · C

Strengths

  • Both molecules are priced on one page, each quoted as medication and programme charge included rather than as a bare drug price
  • A six-month commitment brings tirzepatide down to $133/mo, and the term is published rather than hidden
  • The first month of the membership is free

Where it loses points

  • A $75/mo membership is marketed as a separate product, and whether it is charged on top of the $149 medication rate is not stated anywhere we could find
  • The $133/mo tirzepatide rate advertised on the homepage requires a six-month commitment; the month-to-month rate is $224
  • Both figures are 'starting at' rates, so the cost of a titrated dose is not published
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard